tradingkey.logo

Precipio Inc

PRPO
22.190USD
-1.000-4.31%
Close 12/19, 16:00ETQuotes delayed by 15 min
38.74MMarket Cap
LossP/E TTM

Precipio Inc

22.190
-1.000-4.31%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Precipio Inc

Currency: USD Updated: 2025-12-19

Key Insights

Precipio Inc's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 160/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Precipio Inc's Score

Industry at a Glance

Industry Ranking
160 / 208
Overall Ranking
475 / 4582
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Precipio Inc Highlights

StrengthsRisks
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 96.90% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 18.53M.
Undervalued
The company’s latest PE is -27.55, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 199.00K shares, increasing 11.63% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 20.19K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.14.

Financial Health

Currency: USD Updated: 2025-12-19

The current financial score of Precipio Inc is 4.51, ranking 207/208 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 6.77M, representing a year-over-year increase of 29.91%, while its net profit experienced a year-over-year increase of 87.38%.

Score

Industry at a Glance

Previous score
4.51
Change
0

Financials

4.97

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

4.06

Operational Efficiency

4.51

Growth Potential

4.00

Shareholder Returns

5.00

Precipio Inc's Company Valuation

Currency: USD Updated: 2025-12-19

The current valuation score of Precipio Inc is 7.46, ranking 87/208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -27.55, which is -98.71% below the recent high of -0.36 and -18.30% above the recent low of -32.59.

Score

Industry at a Glance

Previous score
7.46
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 160/208
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-19

No earnings forecast score is currently available for Precipio Inc. The Healthcare Equipment & Supplies industry's average is 7.77.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-19

The current price momentum score of Precipio Inc is 6.32, ranking 152/208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 24.79 and the support level at 20.79, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.77
Change
-0.45

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.741
Neutral
RSI(14)
44.366
Neutral
STOCH(KDJ)(9,3,3)
12.660
Oversold
ATR(14)
1.410
Low Volatility
CCI(14)
-247.125
Oversold
Williams %R
98.069
Oversold
TRIX(12,20)
0.411
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
23.476
Sell
MA10
24.078
Sell
MA20
24.070
Sell
MA50
21.862
Buy
MA100
19.324
Buy
MA200
14.284
Buy

Institutional Confidence

Currency: USD Updated: 2025-12-19

The current institutional shareholding score of Precipio Inc is 3.00, ranking 135/208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 12.29%, representing a quarter-over-quarter decrease of 41.80%. The largest institutional shareholder is The Vanguard, holding a total of 20.19K shares, representing 1.15% of shares outstanding, with 1.77% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
AMH Equity, Ltd.
130.00K
+366.12%
Eklund (David A)
84.25K
--
Cohen (David Seth)
52.94K
+1.71%
BlackRock Institutional Trust Company, N.A.
28.91K
--
Sandberg (Richard A)
25.18K
+248.20%
The Vanguard Group, Inc.
Star Investors
17.64K
--
Andrews (Ronald Asbury)
15.23K
+4.65%
Geode Capital Management, L.L.C.
15.22K
+0.81%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-19

The current risk assessment score of Precipio Inc is 2.67, ranking 150/208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.12. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
2.67
Change
0
Beta vs S&P 500 index
1.12
VaR
+7.19%
240-Day Maximum Drawdown
+55.62%
240-Day Volatility
+109.54%

Return

Best Daily Return
60 days
+18.80%
120 days
+18.80%
5 years
+171.81%
Worst Daily Return
60 days
-9.39%
120 days
-9.39%
5 years
-29.37%
Sharpe Ratio
60 days
+1.52
120 days
+2.19
5 years
+0.24

Risk Assessment

Maximum Drawdown
240 days
+55.62%
3 years
+76.99%
5 years
+95.77%
Return-to-Drawdown Ratio
240 days
+4.96
3 years
+0.08
5 years
-0.12
Skewness
240 days
+1.54
3 years
+1.07
5 years
+12.52

Volatility

Realised Volatility
240 days
+109.54%
5 years
+102.36%
Standardised True Range
240 days
+4.63%
5 years
+7.97%
Downside Risk-Adjusted Return
120 days
+511.59%
240 days
+511.59%
Maximum Daily Upside Volatility
60 days
+72.73%
Maximum Daily Downside Volatility
60 days
+60.25%

Liquidity

Average Turnover Rate
60 days
+0.79%
120 days
+0.78%
5 years
--
Turnover Deviation
20 days
+13.79%
60 days
+35.05%
120 days
+32.74%

Peer Comparison

Healthcare Equipment & Supplies
Precipio Inc
Precipio Inc
PRPO
4.08 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
Edwards Lifesciences Corp
EW
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
Artivion Inc
AORT
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
Tactile Systems Technology Inc
TCMD
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of Precipio Inc?

The TradingKey Stock Score provides a comprehensive assessment of Precipio Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Precipio Inc’s performance and outlook.

How do we generate the financial health score of Precipio Inc?

To generate the financial health score of Precipio Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Precipio Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Precipio Inc.

How do we generate the company valuation score of Precipio Inc?

To generate the company valuation score of Precipio Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Precipio Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Precipio Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Precipio Inc.

How do we generate the earnings forecast score of Precipio Inc?

To calculate the earnings forecast score of Precipio Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Precipio Inc’s future.

How do we generate the price momentum score of Precipio Inc?

When generating the price momentum score for Precipio Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Precipio Inc’s prices. A higher score indicates a more stable short-term price trend for Precipio Inc.

How do we generate the institutional confidence score of Precipio Inc?

To generate the institutional confidence score of Precipio Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Precipio Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Precipio Inc.

How do we generate the risk management score of Precipio Inc?

To assess the risk management score of Precipio Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Precipio Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Precipio Inc.
KeyAI